Insider Transactions in Q2 2021 at Avidity Biosciences, Inc. (RNA)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2021
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
20,100
-74.0%
|
$562,800
$28.55 P/Share
|
|
Jun 25
2021
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,100
+30.35%
|
$0
$0.89 P/Share
|
|
Jun 24
2021
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
100
-6.99%
|
$2,700
$27.75 P/Share
|
|
Jun 24
2021
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+6.54%
|
$100
$1.24 P/Share
|
|
Jun 17
2021
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
200
-13.07%
|
$5,400
$27.75 P/Share
|
|
Jun 17
2021
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+11.56%
|
$200
$1.24 P/Share
|
|
Jun 15
2021
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Indirect |
23,019
-100.0%
|
$598,494
$26.02 P/Share
|
|
Jun 14
2021
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Indirect |
14,003
-37.82%
|
$350,075
$25.92 P/Share
|